NEK2 and breast cancer: This pattern of differential NEK2 expression in BC subtypes was largely confirmed by analysis of data from the METABRIC project [32], even though a moderate but significant upregulation of NEK2 in HER2-positive tumors was observed in this cohort (Additional File 2: Supplemental Fig. 1H-L).